GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » Price-to-Funds-From-Operations

ArcticZymes Technologies ASA (FRA:B4V) Price-to-Funds-From-Operations : (As of Apr. 27, 2025)


View and export this data going back to . Start your Free Trial

What is ArcticZymes Technologies ASA Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


ArcticZymes Technologies ASA Business Description

Traded in Other Exchanges
Address
Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.